Why the study?
Does the combination of simvastatin and amiodarone cause rhabdomyolysis and hepatotoxicity in a patient post-CABG?
Does the combination of simvastatin and amiodarone cause rhabdomyolysis and hepatotoxicity in a patient post-CABG?
Concurrent use of high-dose simvastatin and amiodarone can lead to severe rhabdomyolysis and hepatotoxicity, likely due to CYP3A4 inhibition.
No takes yet. Share an insight, caveat, or question.
May warrant caution with concurrent use post-CABG; extends prior cases but leaves open incidence and alternatives.
Ricaurte et al. (2006) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: